MGTX
Price
$4.15
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
28 days until earnings call
SCPH
Price
$3.94
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
27 days until earnings call
Ad is loading...

MGTX vs SCPH

Header iconMGTX vs SCPH Comparison
Open Charts MGTX vs SCPHBanner chart's image
MeiraGTx Holdings
Price$4.15
Change-$0.00 (-0.00%)
Volume$84.49K
CapitalizationN/A
scPharmaceuticals
Price$3.94
Change-$0.00 (-0.00%)
Volume$263.34K
CapitalizationN/A
View a ticker or compare two or three
MGTX vs SCPH Comparison Chart
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MGTX vs. SCPH commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and SCPH is a Hold.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (MGTX: $4.16 vs. SCPH: $3.94)
Brand notoriety: MGTX and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 42% vs. SCPH: 77%
Market capitalization -- MGTX: $328.8M vs. SCPH: $228.63M
MGTX [@Biotechnology] is valued at $328.8M. SCPH’s [@Biotechnology] market capitalization is $228.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • MGTX’s TA Score: 4 bullish, 1 bearish.
  • SCPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than SCPH.

Price Growth

MGTX (@Biotechnology) experienced а -1.65% price change this week, while SCPH (@Biotechnology) price change was -9.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

MGTX is expected to report earnings on Mar 12, 2025.

SCPH is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($329M) has a higher market cap than SCPH($229M). SCPH YTD gains are higher at: -37.161 vs. MGTX (-40.741). SCPH has higher annual earnings (EBITDA): -51.74M vs. MGTX (-65.93M). MGTX has more cash in the bank: 100M vs. SCPH (38.5M). SCPH has less debt than MGTX: SCPH (41.4M) vs MGTX (87.6M). SCPH has higher revenues than MGTX: SCPH (24M) vs MGTX (8.12M).
MGTXSCPHMGTX / SCPH
Capitalization329M229M144%
EBITDA-65.93M-51.74M127%
Gain YTD-40.741-37.161110%
P/E RatioN/AN/A-
Revenue8.12M24M34%
Total Cash100M38.5M260%
Total Debt87.6M41.4M212%
FUNDAMENTALS RATINGS
MGTX vs SCPH: Fundamental Ratings
MGTX
SCPH
OUTLOOK RATING
1..100
7553
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6085
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGTX's Valuation (52) in the Biotechnology industry is in the same range as SCPH (81) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to SCPH’s over the last 12 months.

MGTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to SCPH’s over the last 12 months.

MGTX's SMR Rating (98) in the Biotechnology industry is in the same range as SCPH (99) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to SCPH’s over the last 12 months.

MGTX's Price Growth Rating (60) in the Biotechnology industry is in the same range as SCPH (85) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to SCPH’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SCPH (100) in the Pharmaceuticals Major industry. This means that MGTX’s stock grew similarly to SCPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXSCPH
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+0.24%
NTLA - MGTX
52%
Loosely correlated
-1.34%
BEAM - MGTX
50%
Loosely correlated
+0.77%
EDIT - MGTX
48%
Loosely correlated
-1.58%
ANNX - MGTX
47%
Loosely correlated
+0.80%
CRSP - MGTX
45%
Loosely correlated
+0.42%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with INZY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-0.88%
INZY - SCPH
44%
Loosely correlated
-2.67%
XERS - SCPH
44%
Loosely correlated
-4.42%
BEAM - SCPH
43%
Loosely correlated
+0.77%
MGTX - SCPH
43%
Loosely correlated
+0.24%
NTLA - SCPH
43%
Loosely correlated
-1.34%
More